Literature DB >> 2891115

Sph I restriction fragment length polymorphism on human chromosome 16 detected with an APRT gene probe.

J E Arrand1, A M Murray, N Spurr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2891115      PMCID： PMC306507          DOI： 10.1093/nar/15.22.9615

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  2 in total

1.  A new location for the human adenine phosphoribosyltransferase gene (APRT) distal to the haptoglobin (HP) and fra(16)(q23)(FRA16D) loci.

Authors:  A Fratini; R N Simmers; D F Callen; V J Hyland; J A Tischfield; P J Stambrook; G R Sutherland
Journal:  Cytogenet Cell Genet       Date:  1986

2.  Cloning the complete human adenine phosphoribosyl transferase gene.

Authors:  A M Murray; E Drobetsky; J E Arrand
Journal:  Gene       Date:  1984-11       Impact factor: 3.688
  2 in total
  4 in total

1.  Crossovers within a short DNA sequence indicate a long evolutionary history of the APRT*J mutation.

Authors:  N Kamatani; S Kuroshima; M Hakoda; T D Palella; Y Hidaka
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

2.  Identification of a splice mutation at the adenine phosphoribosyltransferase locus in a German family.

Authors:  B S Gathof; A Sahota; U Gresser; J Chen; P J Stambrook; J A Tischfield; N Zöllner
Journal:  Klin Wochenschr       Date:  1990-12-30

3.  Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients.

Authors:  N Kamatani; M Hakoda; S Otsuka; H Yoshikawa; S Kashiwazaki
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Diagnosis of heterozygous states for adenine phosphoribosyltransferase deficiency based on detection of in vivo somatic mutants in blood T cells: application to screening of heterozygotes.

Authors:  M Hakoda; H Yamanaka; N Kamatani; N Kamatani
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.